Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.0038240917782026 0.0038240917782026
Stock impact report

Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis

Fortress Biotech, Inc. (FBIO) 
Last fortress biotech, inc. earnings: 11/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: fortressbiotech.com
Company Research Source: GlobeNewswire
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced that the final analysis of data and additional global longitudinal strain response from the Phase 1a/1b trial of Caelum’s CAEL-101 (mAb 11-1F4) for the treatment of relapsed or refractory amyloid light chain (“AL”) amyloidosis will be presented in an oral session at the 16th International Symposium on Amyloidosis, to be held March 26-29, 2018, in Kumamoto, Japan. The Phase 1a/1b trial was conducted at Columbia University. Details of the presentation are as follows: Title: Final Analysis of the Phase 1a/b Study of Fibril-Reactive Monoclonal Antibody 11-1F4 (CAEL-­101) in Patients with AL AmyloidosisSession: AL amyloidosis 3Oral Presentation Number: 39Date and Time: Tuesday, March 27, 2018, at 4:30 p.m. JSTLocation: KKR Hotel KumamotoPresenter: Camille V. Edwards, M.D., Boston Me Show less Read more
Impact Snapshot
Event Time:
FBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
FBIO alerts

from News Quantified
Opt-in for
FBIO alerts

from News Quantified